Article
Prognostic influence of epidermal growth factor receptor mutation and radiological ground glass appearance in patients with early-stage lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands) - 1 Oct 2021
Aokage Keiju, Miyoshi Tomohiro, Wakabayashi Masashi, Ikeno Takashi, Suzuki Jun, Tane Kenta, Samejima Joji, Tsuboi Masahiro
Abstract excerpt
OBJECTIVES: The ADAURA demonstrated the efficacy of osimertinib as adjuvant therapy in patients with resected stage IB-IIIA adenocarcinoma harboring epidermal growth factor receptor (EGFR) mutations. However, it is controversial whether adjuvant therapy should be applied to all these patients because of their heterogeneities. This study aimed to examine the influence of GGO and EGFR mutations on the prognosis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
